XML 66 R41.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Based Compensation (Details) (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Weighted Average Grant Price [Roll Forward]      
Expense resulting from modifications to stock options $ 500,000    
Fair value and assumptions used in determining fair value of stock options [Abstract]      
Volatility (in hundredths) 96.20% 111.60%  
Risk-free interest rate (in hundredths) 0.70% 0.90%  
Dividend yield (in hundredths) 0.00% 0.00%  
Expected option term 6 years 3 months 6 years 3 months  
Weighted-average fair value of stock options granted (in dollars per share) $ 3.21 $ 2.68  
Number of Shares [Roll Forward]      
Options outstanding (in shares) 891,751 214,275 259,275
Granted (in shares) 1,116,384 766,000 0
Exercised (in shares) (30,250) (5,200) 0
Cancelled (in shares) (160,046) (83,324) (45,000)
Options outstanding (in shares) 1,817,839 891,751 214,275
Vested and expected to vest (in shares) 1,692,915 816,414 214,275
Exercisable (in shares) 438,145 125,751 214,275
Weighted Average Exercise Price [Roll Forward]      
Options outstanding (in dollars per share) $ 5.15 $ 18.43 $ 23
Granted (in dollars per share) $ 4.12 $ 3.77 $ 0
Exercised (in dollars per share) $ 7.08 $ 6.16 $ 0
Cancelled (in dollars per share) $ 9.54 $ 26.57 $ 48.04
Options outstanding (in dollars per share) $ 4.10 $ 5.15 $ 18.43
Vested and expected to vest (in dollars per share) $ 4.11 $ 5.30 $ 18.43
Exercisable (in dollars per share) $ 4.59 $ 13.54 $ 18.43
Weighted Average Remaining Contractual Life in Years [Abstract]      
Options outstanding 7 years 10 months 2 days    
Vested and expected to vest 7 years 8 months 16 days    
Exercisable 2 years 5 months 5 days    
Aggregate Intrinsic Value [Abstract]      
Options outstanding 4,790,817    
Vested and expected to vest 4,457,650    
Exercisable 1,003,740    
Total intrinsic value of stock options exercised during the period 24,590,000 23,482,000  
Unrecognized compensation expense related to unvested stock options 5,900,000    
Restricted Stock and Restricted Stock Units [Abstract]      
Number of periods that noncash compensation expense is recognized 2 years    
Number of common shares to be received in lieu of per RS and RSU (in shares) 1,400,000    
Restricted Stock or Unit Expense 1,200,000    
$3.03 to $3.13 [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Range of Exercise Prices lower range limit (in dollars per share) $ 3.03    
Range of Exercise Prices upper range limit (in dollars per share) $ 3.13    
Number of Options outstanding (in shares) 482,305    
Weighted Average Remaining Contractual Term (in Years) 6 years 4 months 6 days    
Weighted Average Exercise Price (in dollars per share) $ 3.03    
Number of Options exercisable (in shares) 234,495    
Weighted Average Exercise Price (in dollars per share) $ 3.03    
$3.14 to $3.39 [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Range of Exercise Prices lower range limit (in dollars per share) $ 3.14    
Range of Exercise Prices upper range limit (in dollars per share) $ 3.39    
Number of Options outstanding (in shares) 21,400    
Weighted Average Remaining Contractual Term (in Years) 9 years 5 months 8 days    
Weighted Average Exercise Price (in dollars per share) $ 3.24    
Number of Options exercisable (in shares) 0    
Weighted Average Exercise Price (in dollars per share) $ 0    
$3.40 to $3.47 [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Range of Exercise Prices lower range limit (in dollars per share) $ 3.4    
Range of Exercise Prices upper range limit (in dollars per share) $ 3.47    
Number of Options outstanding (in shares) 708,314    
Weighted Average Remaining Contractual Term (in Years) 9 years 8 months 8 days    
Weighted Average Exercise Price (in dollars per share) $ 3.4    
Number of Options exercisable (in shares) 0    
Weighted Average Exercise Price (in dollars per share) $ 0    
$3.48 to $4.05 [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Range of Exercise Prices lower range limit (in dollars per share) $ 3.48    
Range of Exercise Prices upper range limit (in dollars per share) $ 4.05    
Number of Options outstanding (in shares) 16,500    
Weighted Average Remaining Contractual Term (in Years) 9 years 6 months 4 days    
Weighted Average Exercise Price (in dollars per share) $ 3.69    
Number of Options exercisable (in shares) 0    
Weighted Average Exercise Price (in dollars per share) $ 0    
$4.55 to $4.96 [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Range of Exercise Prices lower range limit (in dollars per share) $ 4.55    
Range of Exercise Prices upper range limit (in dollars per share) $ 4.96    
Number of Options outstanding (in shares) 186,170    
Weighted Average Remaining Contractual Term (in Years) 9 years 8 months 26 days    
Weighted Average Exercise Price (in dollars per share) $ 4.55    
Number of Options exercisable (in shares) 0    
Weighted Average Exercise Price (in dollars per share) $ 0    
$4.97 to $5.89 [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Range of Exercise Prices lower range limit (in dollars per share) $ 4.97    
Range of Exercise Prices upper range limit (in dollars per share) $ 5.89    
Number of Options outstanding (in shares) 4,000    
Weighted Average Remaining Contractual Term (in Years) 9 years 9 months 0 days    
Weighted Average Exercise Price (in dollars per share) $ 4.97    
Number of Options exercisable (in shares) 0    
Weighted Average Exercise Price (in dollars per share) $ 0    
$5.90 to $6.33 [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Range of Exercise Prices lower range limit (in dollars per share) $ 5.9    
Range of Exercise Prices upper range limit (in dollars per share) $ 6.33    
Number of Options outstanding (in shares) 198,400    
Weighted Average Remaining Contractual Term (in Years) 1 year 7 months 28 days    
Weighted Average Exercise Price (in dollars per share) $ 5.9    
Number of Options exercisable (in shares) 182,900    
Weighted Average Exercise Price (in dollars per share) $ 5.9    
$6.34 to $8.29 [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Range of Exercise Prices lower range limit (in dollars per share) $ 6.34    
Range of Exercise Prices upper range limit (in dollars per share) $ 8.29    
Number of Options outstanding (in shares) 185,250    
Weighted Average Remaining Contractual Term (in Years) 9 years 7 months 20 days    
Weighted Average Exercise Price (in dollars per share) $ 6.64    
Number of Options exercisable (in shares) 5,250    
Weighted Average Exercise Price (in dollars per share) $ 6.5    
$8.30 to $17.59 [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Range of Exercise Prices lower range limit (in dollars per share) $ 8.3    
Range of Exercise Prices upper range limit (in dollars per share) $ 17.59    
Number of Options outstanding (in shares) 10,250    
Weighted Average Remaining Contractual Term (in Years) 9 months 18 days    
Weighted Average Exercise Price (in dollars per share) $ 9.18    
Number of Options exercisable (in shares) 10,250    
Weighted Average Exercise Price (in dollars per share) $ 9.18    
$17.60 to $17.60 [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Range of Exercise Prices lower range limit (in dollars per share) $ 17.6    
Range of Exercise Prices upper range limit (in dollars per share) $ 17.6    
Number of Options outstanding (in shares) 5,250    
Weighted Average Remaining Contractual Term (in Years) 4 months 10 days    
Weighted Average Exercise Price (in dollars per share) $ 17.6    
Number of Options exercisable (in shares) 5,250    
Weighted Average Exercise Price (in dollars per share) $ 17.6    
2000 Plan [Member]
     
Weighted Average Grant Price [Roll Forward]      
Number of equity compensation plans 2    
Number of additional shares authorized for current and future use (in shares)   3,000,000  
Value of shares that can be purchased under the plan per year 225,000,000,000    
Reserved for future issuance maximum shares of common stock (in shares) 3,925,000    
Shares available for grant (in shares) 737,448    
2000 ESPP [Member]
     
Weighted Average Grant Price [Roll Forward]      
Reserved for future issuance maximum shares of common stock (in shares) 150,000    
Shares available for grant (in shares) 150,000    
Stock Options [Member]
     
Weighted Average Grant Price [Roll Forward]      
Allocated share-based compensation expense 1,800,000 300,000 400,000
Expected weighted average period for recognizing unrecognized compensation expense 3 years 6 months 22 days    
Aggregate Intrinsic Value [Abstract]      
Expected weighted average period for recognizing unrecognized compensation expense 3 years 6 months 22 days    
Stock Options [Member] | General and Administrative Expense [Member]
     
Weighted Average Grant Price [Roll Forward]      
Allocated share-based compensation expense 1,500,000 200,000 0
Stock Options [Member] | Research and Development Expense [Member]
     
Weighted Average Grant Price [Roll Forward]      
Allocated share-based compensation expense 300,000 100,000 0
Restricted Stock (RS) [Member]
     
Number of Non Option Outstanding [Roll Forward]      
Outstanding, beginning balance (in shares)     8,772
Granted (in shares)     30,270
Released (in shares)     (39,042)
Weighted Average Grant Price [Roll Forward]      
Outstanding weighted average grant price (in dollars per share)     $ 17.1
Granted (in dollars per share)     $ 8.80
Released (in dollars per share)     $ 10.72
Restricted Stock Units (RSUs) [Member]
     
Number of Non Option Outstanding [Roll Forward]      
Outstanding, beginning balance (in shares) 487,025    
Granted (in shares) 61,011 491,255  
Released (in shares) (322,819)    
Forfeited (in shares) (9,692) (4,230)  
Outstanding, ending balance (in shares) 215,525 487,025  
Expected to Vest (in shares) 206,395    
Weighted Average Grant Price [Roll Forward]      
Outstanding weighted average grant price (in dollars per share) $ 6.37    
Granted (in dollars per share) $ 3.44 $ 6.36  
Released (in dollars per share) $ 4.59    
Forfeited (in dollars per share) $ 5.69 $ 5.13  
Outstanding weighted average grant price (in dollars per share) $ 6.26 $ 6.37  
Expected to Vest (in dollars per share) $ 6.23    
Restricted Stock and Restricted Stock Units [Member]
     
Weighted Average Grant Price [Roll Forward]      
Allocated share-based compensation expense 1,200,000 1,300,000 300,000
Expected weighted average period for recognizing unrecognized compensation expense 10 months 24 days    
Aggregate Intrinsic Value [Abstract]      
Expected weighted average period for recognizing unrecognized compensation expense 10 months 24 days    
Restricted Stock and Restricted Stock Units [Abstract]      
Unrecognized compensation expense related to unvested RSU's 600,000    
Restricted Stock and Restricted Stock Units [Member] | General and Administrative Expense [Member]
     
Weighted Average Grant Price [Roll Forward]      
Allocated share-based compensation expense 800,000 900,000 200,000
Restricted Stock and Restricted Stock Units [Member] | Research and Development Expense [Member]
     
Weighted Average Grant Price [Roll Forward]      
Allocated share-based compensation expense $ 500,000 $ 400,000 $ 100,000